DHR:NYSE
Danaher Corp
$221.55
arrow_downward
-1.84%(-4.16) 1D
$224.40
arrow_upward
+1.29% (+2.85)bedtimeAfter hours
Closed: Sep 30, 4:04:08 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHR...
Open
$223.86
High
$226.11
Low
$219.69
Mkt. cap
155.75B
Avg. vol.
3.88M
Volume
5.25M
Dividend
0.72%
Quarterly dividend
$0.40
Ex-dividend date
Sep 30, 2026
P/E ratio
39.33
52-wk high
$242.80
52-wk low
$160.93
EPS
$5.63
Beta
0.78
Shares outstanding
702.99M
No. of employees
59K
Open
$223.86
High
$226.11
Low
$219.69
Mkt. cap
155.75B
Avg. vol.
3.88M
Volume
5.25M
Dividend
0.72%
Quarterly dividend
$0.40
Ex-dividend date
Sep 30, 2026
P/E ratio
39.33
52-wk high
$242.80
52-wk low
$160.93
EPS
$5.63
Beta
0.78
Shares outstanding
702.99M
No. of employees
59K
News stories
From web sources and news partners
News Corp
·
3 hours ago
Danaher Corp. stock underperforms Wednesday when compared to competitors
MarketWatch
·
3 hours ago
Danaher Corp. stock underperforms Wednesday when compared to competitors
Investing.com Canada
·
7 hours ago
Form 4 Danaher Corporation For: 30 September By Investing.com
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp